Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
- PMID: 8406999
- DOI: 10.1002/ijc.2910550428
Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
Abstract
We have examined p53 protein levels in cell lines selected for resistance to the chemotherapeutic drug cis-diamminedichloroplatinum (II), cisplatin. The majority of the independent cisplatin-resistant clones isolated by a single selection with cisplatin from the ovarian tumour cell line A2780 showed increased levels of p53 protein compared to the parental cell line. Elevated p53 protein levels were also observed in cisplatin-resistant ovarian human tumour lines isolated after multiple exposures to cisplatin (A2780/cp70 and OVIP/DDP). Direct PCR sequencing of p53 cDNAs showed that both the A2780/cp70 and the parental A2780 cell lines had a wild-type p53 gene sequence. The OVIP and OVIP/DDP lines both had a heterozygous mutation at codon 126. Cell-cycle analysis after gamma-irradiation or cisplatin treatment showed evidence of a G1/S and G2/M cell-cycle checkpoint in both A2780/cp70 and the sensitive parental cell lines. However, the resistant cell line A2780/cp70 showed less inhibition of DNA synthesis after gamma-irradiation than the sensitive cell line. Transfection of a mutant p53 gene construct (containing a mutation at codon 143, val to ala) into the A2780/cp70 resistant cells conferred a significantly increased sensitivity to cisplatin, suggesting that p53 is a direct determinant of cisplatin resistance in these cells. However, expression of this mutant p53 in the A2780 cells did not affect sensitivity.
Similar articles
-
Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.Mol Pharmacol. 1998 May;53(5):819-26. Mol Pharmacol. 1998. PMID: 9584207
-
Prolonged wild-type p53 protein accumulation and cisplatin resistance.Biochem Biophys Res Commun. 2001 May 18;283(4):732-7. doi: 10.1006/bbrc.2001.4849. Biochem Biophys Res Commun. 2001. PMID: 11350044
-
Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines.Int J Cancer. 1998 Sep 11;77(6):913-8. doi: 10.1002/(sici)1097-0215(19980911)77:6<913::aid-ijc19>3.0.co;2-1. Int J Cancer. 1998. PMID: 9714063
-
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.Int J Oncol. 2000 Mar;16(3):555-60. doi: 10.3892/ijo.16.3.555. Int J Oncol. 2000. PMID: 10675489
-
Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance.J Inorg Biochem. 1999 Oct;77(1-2):65-70. doi: 10.1016/s0162-0134(99)00144-0. J Inorg Biochem. 1999. PMID: 10626356 Review.
Cited by
-
IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis.J Oncol. 2019 Sep 26;2019:7475295. doi: 10.1155/2019/7475295. eCollection 2019. J Oncol. 2019. PMID: 31662754 Free PMC article.
-
Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels.Immun Ageing. 2009 Mar 5;6:1. doi: 10.1186/1742-4933-6-1. Immun Ageing. 2009. PMID: 19265538 Free PMC article.
-
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.Br J Cancer. 2008 Mar 25;98(6):1085-93. doi: 10.1038/sj.bjc.6604281. Epub 2008 Mar 18. Br J Cancer. 2008. PMID: 18349819 Free PMC article.
-
Cell-cycle arrest and p53 accumulation induced by geldanamycin in human ovarian tumour cells.Cancer Chemother Pharmacol. 1996;37(5):423-8. doi: 10.1007/s002800050407. Cancer Chemother Pharmacol. 1996. PMID: 8599864
-
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.Br J Cancer. 1998 Sep;78(6):745-51. doi: 10.1038/bjc.1998.571. Br J Cancer. 1998. PMID: 9743293 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous